Skip to main content

PIK3-AKT and Its Role in Pancreatic Cancer

  • Chapter
  • First Online:
Role of Tyrosine Kinases in Gastrointestinal Malignancies

Abstract

The pancreas plays an important role in our body to help with maintaining and regulating homeostatic conditions. One of the cellular pathways that play a major role in pancreatic cell growth and division is the phosphatidylinositol-3-kinase-AKT pathway. According to current research studies, even the smallest changes to the phosphatidylinositol-3-kinase-AKT can cause abnormal cellular growth leading to the development of cancerous cells. Currently, there are many treatment options which are targeting the PI3K-AKT signaling pathway. This chapter examines the function of phosphatidylinositol-3-kinase-AKT pathway in pancreatic cancer and discusses current research studies that focus on potential treatment options.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. What Causes Pancreatic Cancer? (n.d.) Retrieved October 13, 2017, from https://www.cancer.org/cancer/pancreatic-cancer/causes-risks-prevention/what-causes.html

  2. Osaki M, Oshimura M, Ito H (2004) PI3K-Akt pathway: its functions and alterations in human cancer. Apoptosis 9(6):667–676. https://doi.org/10.1023/b:appt.0000045801.15585.dd

    Article  CAS  PubMed  Google Scholar 

  3. Mao Y, Xi L, Li Q, Cai Z, Lai Y, Zhang X, Yu C (2016) Regulation of cell apoptosis and proliferation in pancreatic cancer through PI3K/Akt pathway via Polo-like kinase 1. Oncol Rep 36(1):49–56. https://doi.org/10.3892/or.2016.4820

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Chen L, Li Z, Ahmad N, Liu X (2015) Plk1 phosphorylation of IRS2 prevents premature mitotic exit via AKT inactivation. Biochemistry 54:2473–2480. https://doi.org/10.1021/acs.biochem.5b00016

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Wang S, Wu X, Zhang J, Chen Y, Xu J, Xia X, He S, Qiang F, Li A, Shu Y et al (2013) CHIP functions as a novel suppressor of tumour angiogenesis with prognostic significance in human gastric cancer. Gut 62:496–508. https://doi.org/10.1136/gutjnl-2011-301522

    Article  CAS  PubMed  Google Scholar 

  6. Dan HC, Sun M, Kaneko S, Feldman RI, Nicosia SV, Wang HG, Tsang BK, Cheng JQ (2004) Akt phosphorylation and stabilization of X-linked inhibitor of apoptosis protein (XIAP). J Biol Chem 279:5405–5412. https://doi.org/10.1074/jbc.M312044200

    Article  CAS  PubMed  Google Scholar 

  7. Baer R, Cintas C, Therville N, Guillermet-Guibert J (2015) Implication of PI3K/Akt pathway in pancreatic cancer: when PI3K isoforms matter? Adv Biol Regul 59:19–35. https://doi.org/10.1016/j.jbior.2015.05.001

    Article  CAS  PubMed  Google Scholar 

  8. Bowles T, Parsons C, Muilenburg D, Bold R (2009) Targeted inhibition of AKT in pancreatic cancer. Curr Cancer Ther Rev 5(4):288–295. https://doi.org/10.2174/157339409789712654

    Article  CAS  Google Scholar 

  9. Porta C, Paglino C, Mosca A (2014) Targeting PI3K/Akt/mTOR signaling in cancer. Front Oncol 4:64. https://doi.org/10.3389/fonc.2014.00064

    Article  PubMed  PubMed Central  Google Scholar 

  10. Kornmann M, Beger HG, Korc M (1998) Role of fibroblast growth factors and their receptors in pancreatic cancer and chronic pancreatitis. Pancreas 17(2):169–175. https://doi.org/10.1097/00006676-199808000-00010

    Article  CAS  PubMed  Google Scholar 

  11. Agbunag C, Bar-Sagi D (2004) Oncogenic K-ras drives cell cycle progression and phenotypic conversion of primary pancreatic duct epithelial cells. Cancer Res 64(16):5659–5663. https://doi.org/10.1158/0008-5472.can-04-0807

    Article  CAS  PubMed  Google Scholar 

  12. Matsumoto J, Kaneda M, Tada M, Hamada J, Okushiba S, Kondo S, Moriuchi T (2002) Differential mechanisms of constitutive Akt/PKB activation and its influence on gene expression in pancreatic cancer cells. Jpn J Cancer Res 93(12):1317–1326. https://doi.org/10.1111/j.1349-7006.2002.tb01240.x

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Leake K, Singhal J, Nagaprashantha LD, Awasthi S, Singhal SS (2012) RLIP76 regulates PI3K/Akt signaling and chemo-radiotherapy resistance in pancreatic Cancer. PLoS One 7(4):e34582. https://doi.org/10.1371/journal.pone.0034582

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ganji Purnachandra Nagaraju .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Momin, S., Nagaraju, G.P. (2018). PIK3-AKT and Its Role in Pancreatic Cancer. In: Nagaraju, G. (eds) Role of Tyrosine Kinases in Gastrointestinal Malignancies. Springer, Singapore. https://doi.org/10.1007/978-981-13-1486-5_4

Download citation

Publish with us

Policies and ethics